ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME. CMN. 2024;6(2):4972-4983. Accessed August 22, 2025. http://cahiersmagellanes.com/index.php/CMN/article/view/782